Rhythm Pharmaceuticals, Inc. (RYTM)
USD 46.67
(-6.32%)
USD 46.67
(-6.32%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -136.15 Million | -173.42 Million | -146 Million | -121.98 Million | -122.75 Million | -62.05 Million |
| Net Income | -184.67 Million | -181.11 Million | -69.61 Million | -133.99 Million | -140.72 Million | -74.06 Million |
| Depreciation & Amortization | 1.75 Million | 1.67 Million | 1.15 Million | 690 Thousand | 834 Thousand | 442 Thousand |
| Deferred income taxes | -423 Thousand | - | -100 Million | - | - | - |
| Stock-based compensation | 32.55 Million | 19.83 Million | 20.8 Million | 17.45 Million | 11.87 Million | 6.39 Million |
| Change in working capital | 4.8 Million | -19.72 Million | 1.89 Million | -5.89 Million | 5.06 Million | 667 Thousand |
| Other non-cash items | 9.82 Million | 5.91 Million | -250 Thousand | -234 Thousand | 203 Thousand | 4.5 Million |
| Investing Cash Flow | -5.66 Million | 28.02 Million | -62.15 Million | 158.53 Million | -27.97 Million | -87.14 Million |
| Investments in PPE | -47 Thousand | -4.28 Million | -5.43 Million | -214 Thousand | -3.38 Million | -722 Thousand |
| Acquisitions | - | 4 Million | 100 Million | -158.74 Million | 24.58 Million | - |
| Investment purchases | -354.91 Million | -251.93 Million | -524.97 Million | -86.86 Million | -295.82 Million | -248.59 Million |
| Sales/Maturities of investments | 354.96 Million | 284.24 Million | 361.24 Million | 245.61 Million | 271.24 Million | 162.16 Million |
| Other Investing Activities | -5.66 Million | -4 Million | 7 Million | 158.74 Million | -24.58 Million | -86.42 Million |
| Financing Cash Flow | 74.36 Million | 213.82 Million | 166.48 Million | 2 Million | 163.47 Million | 164.68 Million |
| Debt repayment | -7.39 Million | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 48.87 Million | 131.11 Million | 166.48 Million | 161.35 Million | 161.35 Million | 164.68 Million |
| Other Financing Activities | 32.89 Million | 82.71 Million | 166.48 Million | -159.34 Million | 2.12 Million | 164.68 Million |
| Accounts receivables | -8.64 Million | -5.19 Million | -1.25 Million | - | - | - |
| Accounts payables | 14.77 Million | 1.54 Million | 18.31 Million | 10.5 Million | 10.5 Million | 6.95 Million |
| Inventory | -5.7 Million | -2.8 Million | -11 Thousand | - | - | - |
| Other working capital | 4.38 Million | -13.26 Million | -15.15 Million | -16.4 Million | -5.44 Million | -6.28 Million |
| Cash at beginning of period | 128 Million | 59.57 Million | 101.25 Million | 62.69 Million | 49.94 Million | 34.46 Million |
| Cash at end of period | 60.4 Million | 128 Million | 59.57 Million | 101.25 Million | 62.69 Million | 49.94 Million |
| Capital Expenditure | -47 Thousand | -4.28 Million | -5.43 Million | -214 Thousand | -3.38 Million | -722 Thousand |
| Effect of forex changes on cash | -142 Thousand | - | - | - | - | - |
| Net cash flow / Change in cash | -67.59 Million | 68.42 Million | -41.68 Million | 38.56 Million | 12.75 Million | 15.48 Million |
| Free Cash Flow | -136.2 Million | -177.7 Million | -151.43 Million | -122.19 Million | -126.13 Million | -62.77 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -32.26 Million | -141.37 Million | -41.63 Million | -184.67 Million | -44.16 Million | -46.7 Million |
| Depreciation & Amortization | 391 Thousand | 405 Thousand | 417 Thousand | 1.75 Million | 442 Thousand | 442 Thousand |
| Deferred income taxes | - | - | -9.87 Million | -423 Thousand | -235 Thousand | 135 Thousand |
| Stock-based compensation | 10.35 Million | 7.76 Million | 8.67 Million | 32.55 Million | 8.61 Million | 8.89 Million |
| Change in working capital | -2.14 Million | -2.18 Million | 8.9 Million | 4.8 Million | 2.82 Million | -7.34 Million |
| Other non-cash items | 11.63 Million | 104.18 Million | 4.12 Million | 9.82 Million | 3.26 Million | 3.48 Million |
| Investing Cash Flow | -8.56 Million | 30.05 Million | 22.64 Million | -5.66 Million | -94.96 Million | 48.19 Million |
| Investments in PPE | - | -40 Million | 1000.00 | -47 Thousand | -1000.00 | -875 Thousand |
| Acquisitions | - | - | -22.63 Million | - | - | 875 Thousand |
| Investment purchases | -66.31 Million | - | -40.65 Million | -354.91 Million | -169.18 Million | -75.43 Million |
| Sales/Maturities of investments | 57.75 Million | 70.05 Million | 63.29 Million | 354.96 Million | 74.5 Million | 124.5 Million |
| Other Investing Activities | -8.56 Million | -40 Million | 22.63 Million | -5.66 Million | -272 Thousand | -875 Thousand |
| Financing Cash Flow | 146.17 Million | 4.24 Million | 2.42 Million | 74.36 Million | 73.04 Million | -965 Thousand |
| Debt repayment | -2.97 Million | -2.78 Million | -2.57 Million | -7.39 Million | -2.16 Million | -1.3 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 140.25 Million | 7.02 Million | 4.99 Million | 48.87 Million | 50.84 Million | 341 Thousand |
| Other Financing Activities | 8.9 Million | -2.78 Million | -2.57 Million | 32.89 Million | 24.37 Million | -1.3 Million |
| Accounts receivables | -2.9 Million | 172 Thousand | -326 Thousand | -8.64 Million | -710 Thousand | -5.71 Million |
| Accounts payables | 482 Thousand | -1.25 Million | 4.85 Million | 14.77 Million | 4.08 Million | 661 Thousand |
| Inventory | -3.48 Million | 117 Thousand | -862 Thousand | -5.7 Million | -1.58 Million | -690 Thousand |
| Other working capital | 3.76 Million | -1.22 Million | 5.23 Million | 4.38 Million | 1.03 Million | -1.59 Million |
| Cash at beginning of period | 53.42 Million | 60.08 Million | 64.92 Million | 128 Million | 116.01 Million | 109.98 Million |
| Cash at end of period | 161.66 Million | 53.42 Million | 60.4 Million | 60.4 Million | 64.92 Million | 116.01 Million |
| Capital Expenditure | - | -40 Million | 1000.00 | -47 Thousand | -1000.00 | -875 Thousand |
| Effect of forex changes on cash | -301 Thousand | -71 Thousand | -192 Thousand | -142 Thousand | 77 Thousand | -113 Thousand |
| Net cash flow / Change in cash | 108.24 Million | -6.65 Million | -4.51 Million | -67.59 Million | -51.09 Million | 6.02 Million |
| Free Cash Flow | -29.07 Million | -80.74 Million | -29.38 Million | -136.2 Million | -29.25 Million | -41.96 Million |
TNTLF
ALA
NEWINFRA
GALP
ONTEX
VHI